These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26773574)

  • 1. The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.
    Shah B; Berger JS; Allen N; Guo Y; Sedlis SP; Xu J; Perez A; Attubato M; Slater J; Feit F
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):727-737. PubMed ID: 26773574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the AToMIC trial explode concerns of contrast coagulopathy?
    Seto AH; Kern MJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):738-739. PubMed ID: 27865075
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study.
    Bellemain-Appaix A; Beygui F; Lesty C; Gupta S; Silvain J; Le Feuvre C; Cayla G; Allali Y; Montalescot G; Collet JP
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):823-33. PubMed ID: 21618678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
    Sutton AG; Ashton VJ; Campbell PG; Price DJ; Hall JA; de Belder MA
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):346-52. PubMed ID: 12410513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100 (platelet function analyzer).
    D'Anglemont De Tassigny A; IDéE JM; Corot AC
    Invest Radiol; 2001 May; 36(5):276-82. PubMed ID: 11323515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Iodixanol and Ioxaglate for Coronary Optical Coherence Tomography Imaging.
    Christakopoulos GE; Kotsia AP; Christopoulos G; Abdullah SM; Rangan BV; Roesle M; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2015 Dec; 27(12):E287-90. PubMed ID: 26378414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
    Barstad RM; Buchmann MS; Hamers MJ; Orning L; Orvim U; Stormorken H; Sakariassen KS
    Acta Radiol; 1996 Nov; 37(6):954-61. PubMed ID: 8995473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney.
    Deray G; Bagnis C; Jacquiaud C; Dubois M; Adabra Y; Jaudon C
    Invest Radiol; 1999 Jan; 34(1):1-4. PubMed ID: 9888047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate.
    Murakami R; Tajima H; Kumazaki T; Yamamoto K
    Acta Radiol; 1998 Jul; 39(4):368-71. PubMed ID: 9685820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo comparative antithrombotic effects of ioxaglate and iohexol and interaction with the platelet antiaggregant clopidogrel.
    Labarthe B; Idee JM; Burnett R; Corot C
    Invest Radiol; 2003 Jan; 38(1):34-43. PubMed ID: 12496519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary intervention.
    Juergens CP; Khaing AM; McIntyre GJ; Leung DY; Lo ST; Fernandes C; Hopkins AP
    Heart Lung Circ; 2005 Sep; 14(3):172-7. PubMed ID: 16352273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of radiographic contrast media on markers of complement activation and apoptosis in patients with chronic coronary artery disease undergoing coronary angiography.
    Deftereos S; Giannopoulos G; Kossyvakis C; Raisakis K; Kaoukis A; Driva M; Ntzouvara O; Panagopoulou V; Rentoukas I; Nikas DJ; Pyrgakis V; Alpert MA
    J Invasive Cardiol; 2009 Sep; 21(9):473-7. PubMed ID: 19726822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates.
    Markou CP; Chronos NA; Hanson SR
    Thromb Haemost; 2001 Mar; 85(3):488-93. PubMed ID: 11307820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of X-ray contrast media on blood flow properties after coronary angiography.
    Scheller B; Hennen B; Thünenkötter T; Mrowietz C; Markwirth T; Schieffer H; Jung F
    Thromb Res; 1999 Nov; 96(4):253-60. PubMed ID: 10593427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.